Social media

Did you know? MASH (Metabolic dysfunction-associated steatohepatitis) is a progressive liver disease affecting millions — and most don’t even know they have it. Our new blog from Symphony Health, an ICON plc company, d...

ICON is pleased to announce our participation at the upcoming #OCTDACH conference, taking place on 12–13 November at the Kameha Grand in Zurich, Switzerland. We invite you to visit us at booth #8 to learn how we can he...

ICON is pleased to announce our participation at the upcoming #OCTDACH conference, taking place on 12–13 November at the Kameha Grand in Zurich, Switzerland. We invite you to visit us at booth \#8 to learn how we can h...

It was a pleasure for us to connect with so many attendees on Day 1 of #CPHIFrankfurt. We appreciated the opportunity to share how ICON is driving innovation across clinical research, commercialization, and digital healt...

ICON will attend the 18th EBF Open Symposium, taking place from 18–20 November at the Hyatt Regency Barcelona Tower. Join us at booth B-15 to meet our experts and learn how ICON delivers high-quality bioanalytical solut...

ICON will attend the 18th EBF Open Symposium, taking place from 18–20 November at the Hyatt Regency Barcelona Tower. Join us at booth B-15 to meet our experts and learn how ICON delivers high-quality bioanalytical solut...

The EU’s Joint Clinical Assessments (JCAs) are reshaping how clinical evidence is evaluated. Are you ready? ICON’s latest whitepaper offers a strategic roadmap to help health technology developers navigate the evolving H...

The EU’s Joint Clinical Assessments (JCAs) are reshaping how clinical evidence is evaluated. Are you ready? ICON’s latest whitepaper offers a strategic roadmap to help health technology developers navigate the evolving H...

On 4 – 6 November in Boston, MA, ICON will be sponsoring the World Drug Safety Congress. This leading event brings together more than 2,000 drug safety professionals from across pharma, biotech, regulatory authorities, a...

On 4 – 6 November in Boston, MA, ICON will be sponsoring the World Drug Safety Congress. This leading event brings together more than 2,000 drug safety professionals from across pharma, biotech, regulatory authorities, a...

Every successful clinical trial begins long before the first patient visit. Site selection and activation play a critical role in ensuring that trials start efficiently and deliver meaningful outcomes. Our latest blog e...

Every successful clinical trial begins long before the first patient visit. Site selection and activation play a critical role in ensuring that trials start efficiently and deliver meaningful outcomes. Our latest blog e...